

NAME OF DRUG: Oxymorphone
(Numorphan) |
| PHYSICAL CHARACTERISTICS: Occurs as a
white or slightly off white, odorless powder. It is sparingly soluble in alcohol
and ether, but freely soluble in water. |
| DOSAGE/OCCURRENCE/USAGE: Oxymorphone
is a semi-synthetic agonist with a chemical structure similar to hydromorphone that
is a narcotic substitute for morphine. It is a potent narcotic analgesic typically
used for the relief of moderate to severe pain and also as a preoperative medication
to alleviate apprehension, maintain anesthesia, and as an obstetric analgesic.
Additionally, it can be used for the alleviation of patients with dyspnea associated
with acute left ventricular failure and pulmonary edema. It is administered
rectally in 5 mg doses four to six times daily, intravenous injection in 0.5 mg
doses, or by subcutaneous or intramuscular injection in 1.0 – 1.5 mg doses four to
six times daily. |
| BLOOD CONCENTRATIONS VS. DOSAGE: Data
regarding therapeutic and toxic plasma concentrations of oxymorphone are not
available. |
| URINE EXCRETION RATE: Oxymorphone is
metabolized to 6-oxymorphol by reduction of the 6-keto group. |
| METABOLITES: Glucuronide conjugates |
| TOXICITY: Oxymorphone overdosage is
characterized by respiratory depression, extreme somnolence progressing to stupor or
coma, skeletal muscle flaccidity, cold and clammy skin, and sometimes bradycardia
and hypotension. In a severe case of overdose, apnea, circulatory collapse,
cardiac arrest, and death may occur. |
REFERENCES:
Baselt, R C. Disposition of Toxic Drugs and Chemicals in Man, Second Edition. Davis,
Calif.: Biomedical Publications, 1982.
Physicians? Desk Reference, Forty-Eight Edition. Montvale, NJ: Medical Economics
Data Production Company, 1994.
Goldberger, Bruce A. Opiates Abused Drugs Monograph Series. Ed. Caplan, Yale H.
Irving, TX: Abbott Laboratories, 1994. |
|
 |